Takeda could rack up $10B in selloffs after controversial Shire buyout: report

Takeda could rack up $10B in selloffs after controversial Shire buyout: report

Source: 
Fierce Pharma
snippet: 

With a crucial shareholder vote looming, Takeda is on an aggressive push to win investor support for a Shire buyout expected to load the company with debt. Now, a top executive says that debt burden could be $10 billion lighter after the deal closes.